Nuvation Bio (NYSE:NUVB) Earns Outperform Rating from Wedbush
Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued on Monday,RTT News reports. They presently have a $5.00 price objective on the stock. Wedbush’s price objective indicates a potential upside of 175.48% from the stock’s previous close. Several other brokerages have also issued reports […]
Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued on Monday,RTT News reports. They presently have a $5.00 price objective on the stock. Wedbush’s price objective indicates a potential upside of 175.48% from the stock’s previous close. Several other brokerages have also issued reports […]
